To invest in Solara Active Pharma shares through Motilal Oswal, open a trading account, complete KYC formalities, transfer funds, log in to the trading platform, search for the shares, buy them, and wait for them to be credited to your demat account.
While Solara’s stock has shed value in the past year, it has now returned to profitability. Additionally, the Founder and Non-Executive Director Arun Pillai bought shares well above current rates to infuse optimism amongst potential investors. That is an indication of confidence in upward movement of the stock.
The financial performance of the company, including revenue growth, profitability, and earnings, can affect its share price. Furthermore, macroeconomic factors such as interest rates, inflation, investor perception of the Indian market, and industry trends can affect Solara’s share price.
Solara Active Pharma shows great potential for growth after amalgamating Aurore Life Science, Empyrean Lifesciences, and Hydra Active Pharma into Solara. Additionally, the WHO recently completed an inspection of the Cuddalore facility, which is expected to boost the share price in the long term.
Solara paid its last dividend of Rs. 3 per share on May 6th, 2021. Despite the company turning a profit in December 2022, there is no news of an upcoming dividend.
Solara Active Pharma has declared dividend four times in the last five years.